Milestone Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$2.05(as of Jan 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Milestone Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.05
Ticker SymbolMIST
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees33
CountyUSA
Market Cap$174.6M

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Milestone Pharmaceuticals Inc In Our Stock Scanner

As of Jan 20, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.